Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal midazolam spray versus intranasal midazolam ampoule for preoperative pediatric sedation
IRCT20120731010453N6Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of midazolam in inguinal hernia (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Preoperative sedation effectiveness. Started Nov 2024; status: completed.
02
Drugs
midazolam
03
Conditions
inguinal hernia
Beyond the preview
Go deeper on IRCT20120731010453N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120731010453N6.